GHK CU vs Matrixyl
Evidence tier, human-evidence strength, regulatory status, and hype-vs-data — side by side.
On published evidence, GHK CU currently grades higher (D-tier vs D-tier). That reflects evidence maturity, not that it's “better” for any person or goal.
- Stronger human evidence: comparable
- More hype than data: neither stands out
| ghk-cu | matrixyl | |
|---|---|---|
| Class | Copper & cosmetic peptides | Copper & cosmetic peptides |
| Regulatory status | Research-use-only | Research-use-only |
| Candidate sources | 0 | 0 |
| Top study types (candidate) | — | — |
| Translation risk | pending review | pending review |
GHK CU vs Matrixyl: FAQ
Is GHK CU better than Matrixyl?
On published evidence, GHK CU currently grades higher (D-tier vs D-tier). That reflects evidence maturity, not that it's “better” for any person or goal. Neither is a recommendation to use anything; this compares the state of the evidence only.
What's the difference between GHK CU and Matrixyl?
GHK CU is research-use-only and sits at the “Early human” evidence stage; Matrixyl is research-use-only and sits at “Early human.”
Which has stronger human evidence, GHK CU or Matrixyl?
Both have comparable human-evidence levels on our scale.
Research reference only. Not medical advice, treatment instructions, or a purchase recommendation. Consult a licensed professional.